• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

镁对磷酸钙形成的影响。

Effects of magnesium on calcium phosphate formation.

作者信息

Cheng P T, Grabher J J, LeGeros R Z

机构信息

University of Toronto, Ont., Canada.

出版信息

Magnesium. 1988;7(3):123-32.

PMID:2846970
Abstract

All biological calcium phosphates form in various neutral aqueous solutions containing [CaCl2] = 1 or 3 mM, [MgCl2] = 0-9 mM, [Na2HPO4] = 0.1-90 mM and NaCl (total 300 mosM) kept quiescently at 37 degrees C for 21 days. In all solutions containing 1 mM Ca and in solutions with [Ca] = 3 mM and [PO4] less than 10 mM, heterogeneous nucleation of octa-calcium phosphate (for Mg/Ca less than or equal to 1) or brushite (for Mg/Ca greater than 1) was observed; the former transforming to apatite with time. In contrast, homogeneous nucleation of an unstable amorphous calcium magnesium phosphate occurred in solutions with [Ca] = 3 mM and [PO4] greater than or equal to 10 mM, transforming to apatite, to brushite, and to whitlockite (and newberyite) depending on Mg/Ca and [PO4] values.

摘要

所有生物磷酸钙在各种中性水溶液中形成,这些溶液含有[CaCl2]=1或3 mM、[MgCl2]=0 - 9 mM、[Na2HPO4]=0.1 - 90 mM以及NaCl(总渗透压为300 mosM),在37℃下静置21天。在所有含1 mM钙的溶液以及钙浓度为3 mM且磷酸根浓度小于10 mM的溶液中,观察到了磷酸八钙(镁钙比小于或等于时)或透钙磷石(镁钙比大于1时)的异质成核现象;前者随时间转化为磷灰石。相比之下,在钙浓度为3 mM且磷酸根浓度大于或等于10 mM的溶液中发生了不稳定的无定形磷酸钙镁的均匀成核现象,根据镁钙比和磷酸根浓度值,其会转化为磷灰石、透钙磷石以及白磷钙矿(和新磷钙石)。

相似文献

1
Effects of magnesium on calcium phosphate formation.镁对磷酸钙形成的影响。
Magnesium. 1988;7(3):123-32.
2
The effects of magnesium on hydroxyapatite formation in vitro from CaHPO4 and Ca4(PO4)2O at 37.4 degrees C.镁在37.4摄氏度下对磷酸氢钙和Ca4(PO4)2O体外形成羟基磷灰石的影响。
Calcif Tissue Int. 1997 Jun;60(6):538-46.
3
[Crystallization of calcium phosphate in the presence of magnesium].[在镁存在的情况下磷酸钙的结晶]
Nephrologie. 1993;14(6):265-9.
4
The interaction of supersaturated calcium phosphate solutions with apatitic substrates.过饱和磷酸钙溶液与磷灰石底物的相互作用。
Calcif Tissue Res. 1976 Apr 13;20(1):75-89. doi: 10.1007/BF02546399.
5
Formation of octacalcium phosphate and subsequent transformation to hydroxyapatite at low supersaturation: a model for cartilage calcification.低过饱和度下八钙磷酸钙的形成及随后向羟基磷灰石的转变:软骨钙化模型
Calcif Tissue Int. 1987 Jun;40(6):339-43. doi: 10.1007/BF02556696.
6
Ethanol-induced formation of solid calcium phosphates.乙醇诱导的固体磷酸钙形成。
Calcif Tissue Int. 1985 Mar;37(2):189-93. doi: 10.1007/BF02554840.
7
Conversion of amorphous tricalcium phosphate into apatitic tricalcium phosphate.无定形磷酸三钙向磷灰石型磷酸三钙的转化。
Calcif Tissue Int. 1982;34 Suppl 2:S103-8.
8
Effects of citrate and NaCl on size, morphology, crystallinity and microstructure of calcium phosphates obtained from aqueous solutions at acidic or near-neutral pH.柠檬酸和 NaCl 对酸性或近中性 pH 下水溶液中获得的磷酸钙的粒径、形貌、结晶度和微观结构的影响。
J Dairy Res. 2012 May;79(2):238-48. doi: 10.1017/S0022029912000076.
9
Biocompatibility of magnesium phosphate minerals and their stability under physiological conditions.磷酸镁矿物的生物相容性及其在生理条件下的稳定性。
Acta Biomater. 2011 Jun;7(6):2678-85. doi: 10.1016/j.actbio.2011.02.007. Epub 2011 Feb 13.
10
Octacalcium phosphate formation in vitro: implications for bone formation.体外磷酸八钙的形成:对骨形成的影响
Calcif Tissue Int. 1985 Jan;37(1):91-4. doi: 10.1007/BF02557685.

引用本文的文献

1
Recent Trends in Hydroxyapatite Supplementation for Osteoregenerative Purposes.用于骨再生目的的羟基磷灰石补充剂的最新趋势。
Materials (Basel). 2023 Feb 3;16(3):1303. doi: 10.3390/ma16031303.
2
Clinical and genetic approach to renal hypomagnesemia.肾脏低镁血症的临床与基因研究方法。
Biomed J. 2022 Feb;45(1):74-87. doi: 10.1016/j.bj.2021.11.002. Epub 2021 Nov 10.
3
Resorbable Mg-Containing Phosphates for Bone Tissue Repair.用于骨组织修复的可吸收含镁磷酸盐。
Materials (Basel). 2021 Aug 26;14(17):4857. doi: 10.3390/ma14174857.
4
Bioactive calcium phosphate materials and applications in bone regeneration.生物活性磷酸钙材料及其在骨再生中的应用。
Biomater Res. 2019 Jan 14;23:4. doi: 10.1186/s40824-018-0149-3. eCollection 2019.
5
Prognostic importance of plasma total magnesium in a cohort of cats with azotemic chronic kidney disease.血浆总镁在氮质血症性慢性肾病猫群中的预后重要性
J Vet Intern Med. 2018 Jul;32(4):1359-1371. doi: 10.1111/jvim.15141. Epub 2018 Apr 27.
6
Dose-response relationship between lower serum magnesium level and higher prevalence of knee chondrocalcinosis.血清镁水平越低与膝关节软骨钙质沉着症患病率越高之间的剂量反应关系。
Arthritis Res Ther. 2017 Oct 24;19(1):236. doi: 10.1186/s13075-017-1450-6.
7
Calcium Phosphate Bioceramics: A Review of Their History, Structure, Properties, Coating Technologies and Biomedical Applications.磷酸钙生物陶瓷:历史、结构、性能、涂层技术及生物医学应用综述
Materials (Basel). 2017 Mar 24;10(4):334. doi: 10.3390/ma10040334.
8
Template-free synthesis of phosphate-based spheres via modified supersaturated phosphate buffer solutions.通过改性过饱和磷酸盐缓冲溶液无模板合成磷酸盐基球体。
J Mater Sci Mater Med. 2017 Jul;28(7):99. doi: 10.1007/s10856-017-5911-x. Epub 2017 May 22.
9
Effects of Magnesium on the Phosphate Toxicity in Chronic Kidney Disease: Time for Intervention Studies.镁对慢性肾脏病中磷毒性的影响:开展干预研究的时机
Nutrients. 2017 Feb 6;9(2):112. doi: 10.3390/nu9020112.
10
Clinical features of CKD-MBD in Japan: cohort studies and registry.日本慢性肾脏病-矿物质和骨异常的临床特征:队列研究与登记
Clin Exp Nephrol. 2017 Mar;21(Suppl 1):9-20. doi: 10.1007/s10157-016-1367-4. Epub 2016 Dec 9.